Arzneimittel – Biologika 2026 (TK)

  • Staat:
  • Stadt: Düsseldorf
  • ID Ausschreibung: 20260010000295917
  • Lieferauftrag
  • Offenes Verfahren
  • Öffentliche Aufträge
  • Wirtschaftlichstes Angebot
Grundinformationen über Ausschreibung
  • Veröffentlicht: 30.04.2026.
  • Läuft ab: 03.06.2026. 12:00
  • Dokumentation zu: -
  • Preis dokumentation: -
  • Wert: -
  • Kategorien (CPV code):
                    33600000 - Arzneimittel
Die Unterlagen im Zusammenhang mit der Ausschreibung


15 Tage kostenlos



Arzneimittel – Biologika 2026 (TK)

Infliximab - TK, hkk, HEK - (ATC: L04AB02); entfällt; Infliximab - DAK-G, KKH - (ATC: L04AB02); Tocilizumab PEN - TK, hkk, HEK - (ATC: L04AC07); Tocilizumab PEN - GWQ - (ATC: L04AC07); Tocilizumab PEN - DAK-G, KKH - (ATC: L04AC07); Tocilizumab IFE - TK, hkk, HEK - (ATC: L04AC07); Tocilizumab IFE - GWQ - (ATC: L04AC07); Tocilizumab IFE - DAK-G, KKH - (ATC: L04AC07); Filgrastim FER - TK, hkk, HEK - (ATC: L03AA02); Filgrastim FER - GWQ - (ATC: L03AA02); Filgrastim FER - DAK-G, KKH - (ATC: L03AA02); Filgrastim IIL - TK, hkk, HEK - (ATC: L03AA02); Filgrastim IIL - GWQ - (ATC: L03AA02); Filgrastim IIL - DAK-G, KKH - (ATC: L03AA02); Omalizumab Fertigspritze - TK, hkk, HEK - (ATC: R03DX05); Omalizumab Fertigspritze - GWQ - (ATC: R03DX05); Omalizumab Fertigspritze - DAK-G, KKH - (ATC: R03DX05); Omalizumab Fertigpen - TK, hkk, HEK - (ATC: R03DX05); Omalizumab Fertigpen - GWQ - (ATC: R03DX05); Omalizumab Fertigpen - DAK-G, KKH - (ATC: R03DX05); Golimumab IFE - TK, hkk, HEK - (ATC: L04AB06); Golimumab IFE - GWQ - (ATC: L04AB06); Golimumab IFE - DAK-G, KKH - (ATC: L04AB06); Tocilizumab IFK - TK, hkk, HEK - (ATC: L04AC07); Tocilizumab IFK - GWQ - (ATC: L04AC07); Tocilizumab IFK - DAK-G, KKH - (ATC: L04AC07); Ranibizumab Fertigspritze - TK, hkk, HEK - (ATC: S01LA04); Ranibizumab Fertigspritze - GWQ - (ATC: S01LA04); Ranibizumab Fertigspritze - DAK-G, KKH - (ATC: S01LA04); Adalimumab Fertigspritze - TK, hkk, HEK - (ATC: L04AB04); Adalimumab Fertigspritze - GWQ - (ATC: L04AB04); Adalimumab Fertigspritze - DAK-G, KKH - (ATC: L04AB04); Adalimumab Fertigpen - TK, hkk, HEK - (ATC: L04AB04); Adalimumab Fertigpen - GWQ - (ATC: L04AB04); Adalimumab Fertigpen - DAK-G, KKH - (ATC: L04AB04); Ranibizumab Durchstechflasche - TK, hkk, HEK - (ATC: S01LA04); Ranibizumab Durchstechflasche - GWQ - (ATC: S01LA04); Ranibizumab Durchstechflasche - DAK-G, KKH - (ATC: S01LA04)



Pharmaceutical products – Biologika 2026 (TK)

Infliximab - TK, hkk, HEK - (ATC: L04AB02); entfällt; Infliximab - DAK-G, KKH - (ATC: L04AB02); Tocilizumab PEN - TK, hkk, HEK - (ATC: L04AC07); Tocilizumab PEN - GWQ - (ATC: L04AC07); Tocilizumab PEN - DAK-G, KKH - (ATC: L04AC07); Tocilizumab IFE - TK, hkk, HEK - (ATC: L04AC07); Tocilizumab IFE - GWQ - (ATC: L04AC07); Tocilizumab IFE - DAK-G, KKH - (ATC: L04AC07); Filgrastim FER - TK, hkk, HEK - (ATC: L03AA02); Filgrastim FER - GWQ - (ATC: L03AA02); Filgrastim FER - DAK-G, KKH - (ATC: L03AA02); Filgrastim IIL - TK, hkk, HEK - (ATC: L03AA02); Filgrastim IIL - GWQ - (ATC: L03AA02); Filgrastim IIL - DAK-G, KKH - (ATC: L03AA02); Omalizumab Fertigspritze - TK, hkk, HEK - (ATC: R03DX05); Omalizumab Fertigspritze - GWQ - (ATC: R03DX05); Omalizumab Fertigspritze - DAK-G, KKH - (ATC: R03DX05); Omalizumab Fertigpen - TK, hkk, HEK - (ATC: R03DX05); Omalizumab Fertigpen - GWQ - (ATC: R03DX05); Omalizumab Fertigpen - DAK-G, KKH - (ATC: R03DX05); Golimumab IFE - TK, hkk, HEK - (ATC: L04AB06); Golimumab IFE - GWQ - (ATC: L04AB06); Golimumab IFE - DAK-G, KKH - (ATC: L04AB06); Tocilizumab IFK - TK, hkk, HEK - (ATC: L04AC07); Tocilizumab IFK - GWQ - (ATC: L04AC07); Tocilizumab IFK - DAK-G, KKH - (ATC: L04AC07); Ranibizumab Fertigspritze - TK, hkk, HEK - (ATC: S01LA04); Ranibizumab Fertigspritze - GWQ - (ATC: S01LA04); Ranibizumab Fertigspritze - DAK-G, KKH - (ATC: S01LA04); Adalimumab Fertigspritze - TK, hkk, HEK - (ATC: L04AB04); Adalimumab Fertigspritze - GWQ - (ATC: L04AB04); Adalimumab Fertigspritze - DAK-G, KKH - (ATC: L04AB04); Adalimumab Fertigpen - TK, hkk, HEK - (ATC: L04AB04); Adalimumab Fertigpen - GWQ - (ATC: L04AB04); Adalimumab Fertigpen - DAK-G, KKH - (ATC: L04AB04); Ranibizumab Durchstechflasche - TK, hkk, HEK - (ATC: S01LA04); Ranibizumab Durchstechflasche - GWQ - (ATC: S01LA04); Ranibizumab Durchstechflasche - DAK-G, KKH - (ATC: S01LA04)